Narrow search
Showing 1 - 10 of 6,634
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017
Persistent link: https://www.econbiz.de/10011708133
Cover Image
Evaluating the US pharmaceutical patent policy
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Cover Image
Optimal patent policy for pharmaceutical industry
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2020
Persistent link: https://www.econbiz.de/10012439514
Cover Image
Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market
Bokhari, Farasat A. S.; Yan, Weijie - 2020
pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive …
Persistent link: https://www.econbiz.de/10012285099
Cover Image
Pseudo-generic products and barriers to entry in pharmaceutical markets : comment
Rodrigues, Vasco - In: Review of industrial organization : RIO 28 (2006) 2, pp. 183-187
Persistent link: https://www.econbiz.de/10003304135
Cover Image
Pseudo-generic products and barriers to entry in pharmaceutical markets : reply
Kong, Ying; Seldon, James R. - In: Review of industrial organization : RIO 28 (2006) 2, pp. 189-193
Persistent link: https://www.econbiz.de/10003304144
Cover Image
Vaccine marketing
Angelmar, Reinhard; Morgon, Pierre A. - 2012
Persistent link: https://www.econbiz.de/10009572811
Cover Image
From free entry to patent protection : welfare implications for the Indian pharmaceutical industry
Dutta, Antara - In: The review of economics and statistics 93 (2011) 1, pp. 160-178
Persistent link: https://www.econbiz.de/10009160721
Cover Image
The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-Day exclusivity period
Olson, Luke M.; Wendling, Brett W. - 2013
Persistent link: https://www.econbiz.de/10010473653
Cover Image
Essays in regulation of pharmaceutical markets
Méndez Vera, Susan Johanna - 2013
Persistent link: https://www.econbiz.de/10010415607